CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 45 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-15 | BOLNO PAUL President and CEO | Sale | −34,935 | $45.45 | $1.6M | 346,274 |
| 2019-03-15 | BOLNO PAUL President and CEO | Sale | −5,065 | $45.89 | $232K | 341,209 |
| 2019-03-15 | BOLNO PAUL President and CEO | Sale | −8,237 | $45.22 | $372K | 332,972 |
| 2019-03-15 | BOLNO PAUL President and CEO | Sale | −1,763 | $46.00 | $81K | 331,209 |
| 2019-03-15 | BOLNO PAUL President and CEO | Exercise or conversion · Share Option (right to buy) | −50,000 | 322,778 | ||
| 2019-03-11 | Panzara Michael A. Franchise Lead, Neurology | Sale | −7,000 | $48.00 | $336K | 45,388 |
| 2019-03-07 | Regnante Keith Chief Financial Officer | Grant or award | +13,500 | 29,186 | ||
| 2019-03-07 | Panzara Michael A. Franchise Lead, Neurology | Grant or award | +15,000 | 52,388 | ||
| 2019-03-07 | BOLNO PAUL President and CEO | Grant or award | +60,000 | 331,209 | ||
| 2019-03-07 | Francis Chris | Grant or award | +13,500 | 33,868 | ||
| 2019-03-07 | Vargeese Chandra Senior VP, Drug Discovery | Grant or award | +15,000 | 40,245 | ||
| 2019-02-19 | Regnante Keith Chief Financial Officer | Sale | −1,298 | $36.84 | $48K | 15,686 |
| 2019-02-19 | Panzara Michael A. Franchise Lead, Neurology | Sale | −1,837 | $36.84 | $68K | 37,388 |
| 2019-02-19 | BOLNO PAUL President and CEO | Sale | −7,614 | $36.38 | $277K | 271,328 |
| 2019-02-19 | BOLNO PAUL President and CEO | Sale | −119 | $37.47 | $4K | 271,209 |
| 2019-02-19 | Vargeese Chandra Senior VP, Drug Discovery | Sale | −2,055 | $36.84 | $76K | 25,245 |
| 2019-02-19 | Francis Chris | Sale | −1,709 | $36.84 | $63K | 20,368 |
| 2019-01-24 | RA CAPITAL MANAGEMENT, LLC Director | Purchase | +263,158 | $38.00 | $10.0M | 7,775,207 |
| 2018-11-14 | Verdine Gregory L. Director | Sale | −10,700 | $38.59 | $413K | 64,339 |
| 2018-11-14 | Verdine Gregory L. Director | Sale | −4,300 | $39.52 | $170K | 60,039 |
Page 19 of 22 · 433 trades